These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 2889804

  • 1. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.
    Sivam SP, Breese GR, Krause JE, Napier TC, Mueller RA, Hong JS.
    J Neurochem; 1987 Nov; 49(5):1623-33. PubMed ID: 2889804
    [Abstract] [Full Text] [Related]

  • 2. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 3. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats.
    Jiang HK, Wang JY.
    Chin J Physiol; 1991 Jan; 34(4):413-25. PubMed ID: 1687937
    [Abstract] [Full Text] [Related]

  • 4. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK, McGinty JF, Hong JS.
    Brain Res; 1990 Jan 15; 507(1):57-64. PubMed ID: 1967976
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.
    Engber TM, Boldry RC, Kuo S, Chase TN.
    Brain Res; 1992 May 29; 581(2):261-8. PubMed ID: 1356580
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE, Wooten GF.
    Brain Res Mol Brain Res; 1992 Jan 29; 12(1-3):111-9. PubMed ID: 1312196
    [Abstract] [Full Text] [Related]

  • 7. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
    Sivam SP.
    Brain Res; 1989 Oct 23; 500(1-2):119-30. PubMed ID: 2481560
    [Abstract] [Full Text] [Related]

  • 8. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR, Napier TC, Mueller RA.
    J Pharmacol Exp Ther; 1985 Aug 23; 234(2):447-55. PubMed ID: 3926987
    [Abstract] [Full Text] [Related]

  • 9. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 10. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
    Bronstein DM, Ye H, Pennypacker KR, Hudson PM, Hong JS.
    Brain Res Mol Brain Res; 1994 May 10; 23(3):191-203. PubMed ID: 7914658
    [Abstract] [Full Text] [Related]

  • 11. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
    Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR.
    Science; 1990 Dec 07; 250(4986):1429-32. PubMed ID: 2147780
    [Abstract] [Full Text] [Related]

  • 12. Dopaminergic regulation of proenkephalin-A gene expression in the basal ganglia.
    Sivam SP, Breese GR, Napier TC, Mueller RA, Hong JS.
    NIDA Res Monogr; 1986 Dec 07; 75():389-92. PubMed ID: 2893272
    [Abstract] [Full Text] [Related]

  • 13. Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
    Breese GR, Baumeister A, Napier TC, Frye GD, Mueller RA.
    J Pharmacol Exp Ther; 1985 Nov 07; 235(2):287-95. PubMed ID: 3932640
    [Abstract] [Full Text] [Related]

  • 14. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
    Frau L, Morelli M, Simola N.
    Exp Neurol; 2013 Sep 07; 247():663-72. PubMed ID: 23499830
    [Abstract] [Full Text] [Related]

  • 15. Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
    Taylor MD, De Ceballos ML, Rose S, Jenner P, Marsden CD.
    Eur J Pharmacol; 1992 Aug 25; 219(2):183-92. PubMed ID: 1385171
    [Abstract] [Full Text] [Related]

  • 16. Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems.
    Sivam SP, Cox J.
    Brain Res; 2006 Feb 16; 1073-1074():159-63. PubMed ID: 16455064
    [Abstract] [Full Text] [Related]

  • 17. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum.
    Li SJ, Jiang HK, Stachowiak MS, Hudson PM, Owyang V, Nanry K, Tilson HA, Hong JS.
    Brain Res Mol Brain Res; 1990 Aug 16; 8(3):219-25. PubMed ID: 1977070
    [Abstract] [Full Text] [Related]

  • 18. Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression.
    Basura GJ, Walker PD.
    Brain Res Mol Brain Res; 2000 Sep 30; 81(1-2):80-91. PubMed ID: 11000480
    [Abstract] [Full Text] [Related]

  • 19. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis.
    Gerfen CR, McGinty JF, Young WS.
    J Neurosci; 1991 Apr 30; 11(4):1016-31. PubMed ID: 1707092
    [Abstract] [Full Text] [Related]

  • 20. Nigrostriatal dopamine mediates the stimulatory effects of corticotropin releasing factor on methionine-enkephalin and dynorphin release from the rat neostriatum.
    Sirinathsinghji DJ, Nikolarakis KE, Reimer S, Herz A.
    Brain Res; 1990 Aug 27; 526(1):173-6. PubMed ID: 1981853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.